Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Humanitarian Device Provision Absent From CMS Clinical Research Proposal

This article was originally published in The Gray Sheet

Executive Summary

CMS' proposed new Medicare coverage policy for clinical research does not include coverage for all humanitarian-use devices in clinical trials, a provision that had been endorsed by an agency advisory panel and medical device companies

You may also be interested in...



CMS Sticks To Status Quo On Clinical Research Coverage, For Now

Major revisions to CMS' policy on covering clinical research costs were put on hold July 9 in response to stakeholder demands for more input

CMS Sticks To Status Quo On Clinical Research Coverage, For Now

Major revisions to CMS' policy on covering clinical research costs were put on hold July 9 in response to stakeholder demands for more input

CMS Research Policy May Deny Coverage For Hundreds Of Device Trials

CMS' proposed Clinical Research Policy has generated widespread concern within the device industry about its potential to restrict Medicare support for clinical trials

Related Content

UsernamePublicRestriction

Register

MT024688

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel